Jane Street Group, LLC Neuronetics, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$3.44 - $6.87 $194,710 - $388,855	56,602 New	56,602 $388,000
Q4 2021 Feb 15, 2022	SELL	$3.87 - $6.59 $41,463 - $70,605	-10,714 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$6.22 - $15.54 $16,520 - $41,274	-2,656 Reduced 19.87%	10,714 $70,000
Q2 2021 Aug 16, 2021	BUY	$10.15 - $17.25 $135,705 - $230,632	13,370 New	13,370 $214,000
Q3 2020 Nov 17, 2020	SELL	$1.82 - $5.87 $80,957 - $261,109	-44,482 Closed	0 $0

Q2 2020 Aug 17, 2020	BUY	$1.41 - $2.61 $62,719 - $116,098	44,482 New	44,482 $86,000

18.4M

200

3.6K

Ticker STIM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 27,022,800
Market Cap $49.7M
Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.